Stephanie Venn-Watson is the Co-Founder and Co-CEO of Seraphina Therapeutics, Inc. and Epitracker, Inc. Seraphina Therapeutics is a consortium of scientists, doctors, and innovators dedicated to challenging traditional approaches to nutrition through metabolomics and advanced technologies, creating natural and safe health products to support quality of life.